Hypothesis: Serum bicarbonate (HCO 3 ) measurement may accurately and reliably be substituted for the arterial base deficit (BD) assay in the surgical intensive care unit (ICU).
A CID-BASE DISTURBANCES ARE commonly encountered in all critically ill patient populations. Early and accurate identification and correction of significant metabolic acidoses are particularly relevant to patients in the surgical intensive care unit (ICU). 1 An arterial blood gas and serum chemistry profile are commonly used to classify the types of acid-base disequilibrium. The arterial base deficit (BD) is directly calculated from the blood gas analyzer from the PCO 2 , pH, and serum bicarbonate (HCO 3 ) values as applied to a standard nomogram and represents the number of milliequivalents of additional base that must be added to a liter of blood to normalize the pH. An elevated BD is thought to represent the presence of unmeasured anions and is usually taken as a surrogate marker of lactic acidosis. 2 The severity of metabolic acidosis as indicated by the measurement has been demonstrated to predict ICU and hospital mortality, [3] [4] [5] [6] length of stay and hospital morbidity, 5, 7, 8 severity of sepsis and organ failure, 9 the presence of bowel ischemia, 10 and transfusion requirements 11 in both medical and surgical or trauma ICU populations. In addition to providing prognostic information, many centers use normalization of the BD over multiple measurements as an end point of therapy or resuscitation. 6, [12] [13] [14] [15] However, measurement of the arterial BD requires an arterial puncture and often necessitates multiple arterial punctures or placement of an indwelling arterial catheter. This has been associated with significant pain, increased hospital costs, and complications such as infection, pseudoaneurysm, distal embolization, and, in rare cases, hand or limb loss. [16] [17] [18] [19] [20] In addition, arterial blood gas mea-surement is not routinely performed in all ICU patients, which could result in a failure or delay in the diagnosis of significant acidosis.
The increased concentrations of plasma hydrogen ions with metabolic acidosis are buffered by a variety of homeostatic mechanisms, including plasma bicarbonates (HCO 3 ). 21 Serum HCO 3 levels have been shown to decrease in a linear fashion with increasing acid loads 22, 23 and theoretically should provide information similar to the arterial BD. In addition, plasma HCO 3 measurement is part of the routine chemistry panel obtained on nearly all ICU admissions, does not require any separate equipment to obtain or perform analysis, and does not require arterial puncture or catheterization. The aims of this study were to examine the degree of correlation between the arterial BD and serum HCO 3 levels, to analyze the accuracy of serum HCO 3 in identifying significant metabolic acidosis, and to compare their ability to predict mortality in a surgical ICU population.
METHODS
This study was designed as a retrospective criterion standard analysis to compare the use of serum HCO 3 levels with the standard measure of arterial BD in an ICU population. The Los Angeles County Hospital (Los Angeles, Calif ) is a large tertiary care facility and level I trauma center with a 16-bed surgical ICU. The study population included all adult (Ͼ14 years) patients admitted to the surgical ICU by either the Emergency Non-Trauma Surgery Service or one of the general surgical specialty services (Thoracic Foregut, Hepatobiliary, Colorectal, or Vascular) from January 1, 1996, to January 1, 2004. Only patients with an ICU stay longer than 24 hours and adequate laboratory data for analysis were included.
Patients were identified from a prospectively maintained clinical and laboratory database of all surgical ICU admissions. Patients who met the foregoing criteria and had at least 1 simultaneously drawn arterial blood gas determination (with BD) and serum chemistry panel (with HCO 3 ) were included. Laboratory, demographic, and outcome data for each patient were entered into a computerized spreadsheet. The Simplified Acute Physiology Score II and the Acute Physiology and Chronic Health Evaluation II score at 24 hours after ICU admission were calculated and recorded. 24, 25 The correlation between HCO 3 and BD was assessed by calculation of the Pearson correlation coefficient (r) and the coefficient of determination (R 2 ), and linear regression analysis was used to develop a predictive equation for BD. The predictive ability of HCO 3 and 3 conventional measures (pH, lactate, and anion gap [AG]) of severe metabolic acidosis and mortality were examined by calculating the area under the receiver operating characteristic curve (AUC). Severe metabolic acidosis was defined as a BD greater than 5. The AG was calculated with the following formula:
where Na indicates the level of sodium; K, of potassium; and Cl, of chloride. Linear variables are reported as the mean value ±1 SD and AUC with 95% confidence intervals. All statistical analysis was performed with SPSS 12.0 for Windows (SPSS Inc, Chicago, Ill), and statistical significance was set at PϽ.05. This study was reviewed and approved with waiver of informed consent by the hospital's institutional review board.
RESULTS
Among 7241 surgical ICU admissions, 2291 patients (32%) were identified who met the inclusion criteria and had adequate laboratory data for analysis. These patients had a total of 26 063 sets of simultaneously obtained paired laboratory data, including an arterial blood gas and serum chemistry panel with serum HCO 3 . The patient demographics are shown in Table 1 . The majority of patients (56%) were admitted to the Emergency Non-Trauma Surgery Service for major abdominal surgery or disease. There were 174 deaths in the ICU, for an overall ICU mortality rate of 8%. Table 2 shows the mean relevant laboratory values for the study population, for both the ICU admission laboratory studies only and for the entire ICU stay. There was a mean BD of 1.9 at ICU admission, which improved to 0.1 for the ICU stay. Similarly, the mean HCO 3 level at admission was 19.8 mEq/L, with improvement to a mean of 23.9 mEq/L for the ICU stay. Correlation and regression analysis demonstrated a very strong correlation between the arterial BD and the simultaneously measured serum HCO 3 levels. Figure 1 shows the strong linear 
From this equation, 2 important cutoff points for clinical use would be a serum HCO 3 level of 22 mEq/L, which equals a BD of 0, and a serum HCO 3 level of 18 mEq/L, which equates to a BD of 5.
We then assessed the accuracy and reliability of serum HCO 3 level for the identification of significant metabolic acidoses (BDϾ5) and compared this with other conventional measures of acidosis such as pH, anion gap, and lactate. The serum HCO 3 level reliably and accurately identified the presence of a significant acidosis, with an AUC of 0.93 (95% confidence interval, 0.92-0.94; PϽ.001) for the ICU admission laboratory studies and 0.95 (95% confidence interval, 0.94-0.96; PϽ.001) for the entire data set (Figure 2 ). The serum HCO 3 significantly outperformed the other conventional acid-base measures examined, including the arterial pH (AUC, 0.80), serum anion gap (AUC, 0.70), and arterial lactate (AUC, 0.70).
The study laboratory values were then analyzed for their ability to predict ICU mortality. Nonsurvivors were older, had a higher Simplified Acute Physiology Score II and Acute Physiology and Chronic Health Evaluation II score, and demonstrated significant differences in pH, anion gap, HCO 3 , BD, and lactate at the time of ICU admission compared with survivors ( Table 3 ). The receiver operating characteristic curves for mortality prediction demonstrated that the serum HCO 3 performed as well as the arterial BD, with AUCs of 0.68 and 0.70 (both PϽ.001), respectively (Figure 3 ). Both measures outperformed the admission arterial pH (AUC, 0.61) and serum anion gap (AUC, 0.59) for predicting ICU deaths. Analysis of the entire data set demonstrated that BD and HCO 3 level maintained similar predictive power throughout the ICU stay, with an AUC of 0.64 for BD and 0.63 for serum HCO 3 level (both PϽ.001).
COMMENT
The diagnosis and management of major disturbances in acid-base homeostasis are a routine aspect of caring for critically ill or injured patients across all medical and surgical specialties. Acute changes in pH can produce significant alterations in the physical and electrochemical functions from the cellular to the organ and system levels. 21, 23, 26, 27 Metabolic acidosis remains one of the more concerning acid-base disturbances in the acutely ill surgical patient, as it often reflects ongoing tissue or organ hypoperfusion, which can result in organ failure or death if not promptly corrected. 5, 6, 15 Multiple techniques to identify the presence of acidosis and/or tissue hypoperfusion have been studied and used, including systemic markers such as the arterial BD, 28 anion gap, 29 lactate, 30 and mixed venous oxygen saturation, 15 as well as tissue-or organ-specific measures such as gastric tonometry, 31 sublingual capnometry, 32 and transcutaneous oxygen or carbon dioxide monitoring. 33 Although there is ongoing debate about the relative merits of each measure, the ideal marker would be easily obtained and analyzed, provide accurate and reliable clinical information, and be costeffective.
The arterial BD remains one of the most commonly used markers in the ICU both to diagnose the presence of metabolic acidosis and to guide resuscitation or therapy. Although an elevated BD is often taken as a surrogate marker for lactic acidosis in the perioperative or acute illness setting, a variety of mechanisms contribute to metabolic acidosis in the surgical ICU. 4, [34] [35] [36] Thus, while the level of serum lactate appears to be a more specific predictor of ICU and hospital mortality, 5, 37, 38 the arterial BD remains a more sensitive measure of the overall degree of metabolic acidosis from all causes. 23 In trauma patients, several series have demonstrated that the admission BD is predictive of hospital mortality and morbidity and that normalization of the BD during the initial resuscitation correlates with improved outcomes. 6, 28, 39, 40 The BD has also been used extensively in other medical and surgical ICU populations. In a series of 104 patients with acute pancreatitis, Sanchez-Lozada et al 7 reported that the admission arterial BD predicted disease severity with a sensitivity of 71% and mortality with a sensitivity of 100%. Takeuchi et al 10 found that the BD predicted the presence of intestinal gangrene in a series of patients with small-bowel obstruction and that the absolute level of BD correlated with the size of the ne-crotic segment of bowel. Other series have demonstrated that BD independently predicts perioperative mortality after ruptured abdominal aortic aneurysm repair, 8 predicts mortality and the development of multiple organ dysfunction after thermal injury, 9 and correlates with the ICU length of stay after cardiac surgery. 41 In a study of 438 patients undergoing elective noncardiac surgery, Bennett-Guerrero et al 42 found that BD independently predicted postoperative complications and increased length of stay (P=.008), whereas standard variables such as heart rate, blood pressure, temperature, and urine output did not. In addition, the BD has been shown to be superior to other conventional measures of acidosis, such as the arterial pH or the serum anion gap. 4, 28, 43, 44 Our data confirm that nonsurvivors in a surgical ICU population have significant BD elevations, that both the admission and serially obtained BDs are predictive of ICU mortality, and that the BD clearly outperforms other measures such as pH and anion gap.
Although the arterial BD has demonstrated utility for diagnosis, for prognosis, and as a guide to therapy, there are several drawbacks to its use. The main drawbacks involve the need for arterial puncture (single or multiple) or arterial catheterization. In an audit of patients undergoing arterial puncture, 49% recalled pain levels greater than 5 of 10, and 49% were poorly informed regarding the procedure. 16 Although infrequent, other complications associated with arterial puncture or catheterization can range from minor hematoma formation to devastating ischemia and limb loss. [17] [18] [19] [20] 45 Patient factors such as obesity, diminutive arteries, and hypovolemia may make obtaining an adequate specimen difficult or impossible. In addition, processing of the arterial sample requires specialized equipment for collection, storage, and analysis, with resultant increase in costs to the hospital and patient. 46 The substitution of an easily measured value from a venous sample, such as the serum HCO 3 , would overcome most of these drawbacks if it provided clinical information equivalent to the arterial BD.
There are few published data examining the utility of using the serum HCO 3 to provide information equivalent to the arterial BD in the ICU. In patients with chronic acidosis undergoing dialysis, serum HCO 3 levels have been demonstrated to correlate with nutritional status, hospitalization rates, and mortality. 47, 48 In a large series of patients with septic shock, serum HCO 3 levels demonstrated a moderate correlation with the degree of lactic acidosis but were not directly compared with BD. 38 Eachempati et al 12 performed the only study to date that has objectively described the relationship between simultaneously measured arterial BD and serum HCO 3 levels, which served as the impetus for this study. They found a strong linear correlation between the 2 measures (r=0.91, R 2 =0.83) in a mixed trauma and surgical ICU population, and derived a regression equation to predict the BD from a known HCO 3 level. Although they demonstrated a high degree of overall correlation, they did not analyze the performance of the serum HCO 3 in the most clinically important area, identifying or excluding a significant metabolic acidosis. In addition, inclusion of a more homogeneous population (trauma) with a more mixed group of patients (nontrauma surgical) could po- tentially overestimate the degree of correlation and utility of serum HCO 3 in the nontrauma patients.
Our results do demonstrate a strong linear correlation between these 2 measures in a nontrauma surgical ICU population, with correlation coefficients only slightly weaker (r=0.88 vs 0.91 and R 2 = 0.77 vs 0.83) than those reported by Eachempati et al. 12 Our receiver operating characteristic curves for prediction of significant acidosis and mortality also demonstrate that serum HCO 3 measurement provides nearly identical information as arterial BD in this patient population, both at the time of ICU admission and throughout the ICU stay. The serum HCO 3 level also provided better diagnostic and prognostic information than other conventional measures, such as the arterial pH and the serum anion gap.
This study has several limitations. Although a strong and reliable relationship was found between the 2 main study variables in the entire population, there may have been unidentified subgroups of patients in whom this relationship may have been altered or even invalid. Measurement of the arterial BD is only one of several major indications for arterial puncture or catheterization in the ICU population, and adoption of this practice would potentially decrease but would not eliminate the need for arterial puncture. Because of the nature of this retrospective review, we are unable to comment on the percentage of patients in this study who had other indications for arterial catheterization, such as hemodynamic or respiratory instabililty. Although we have identified several local complications from arterial manipulation in these patients, including hand ischemia, our database did not track the overall number or type of arterialrelated complications.
In conclusion, these results indicate that the serum HCO 3 determination may be safely and reliably substituted for measurement of arterial BD in the surgical ICU patient. Potential advantages of this approach include increased patient comfort, avoidance of complications associated with arterial puncture and cannulation, and cost savings in terms of both time and equipment. These data should also improve the understanding that low serum HCO 3 levels accurately identify metabolic acidosis and should prompt immediate evaluation and potential interventions. is that it would. That is because trauma patients are a more homogeneous group of patients with fewer comorbidities and their major problem is often blood loss.
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In regard to the logistic regression analysis that you suggested, we did not do that. We felt that there had been enough studies showing that the BD correlated well with mortality and other outcome measures.
Just one small point: in the equation for the calculation of blood gases, the arterial HCO 3 is actually a calculated value, not a measured number.
Dr Mullins, you asked us where these bloods came from. The arterial blood gases for the BDs that we reported were all arterial, and peripheral venous blood was used for the bicarbonates. We usually resuscitate patients with Ringer lactate, but there is some use of normal saline in the emergency department and on Internal Medicine.
Dr Shabot had a question about why we did not do a Bland-Altman analysis to compare the HCO 3 and BD measurements. Our understanding is that a Bland-Altman plot would be most appropriate when comparing 2 tests that are trying to measure or quantify the same thing, for instance, comparing 2 methods of estimating a patient's cardiac output. It is a test to see how close the paired estimates come to each other. This would not be appropriate in our study, as we are comparing 2 distinctly different clinical measurements with different values and scales. Our statisticians believe that the most appropriate test to determine how well each of these measures functions as a test is an analysis of the receiver operating characteristic curves.
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